60 results
Page 2 of 3
424B5
wcota7th ix85c3
31 Dec 19
Prospectus supplement for primary offering
4:28pm
424B3
rpqpmnx254
18 Nov 19
Prospectus supplement
4:53pm
8-K
EX-99.1
1sy9i
9 Sep 19
Regulation FD Disclosure
6:50am
8-K
EX-99.1
m6895zf47i
14 May 19
EyeGate Pharma Receives Positive Nasdaq Listing Determination
6:55am
8-K
EX-99.1
raayvm wf
12 Dec 18
Regulation FD Disclosure
4:30pm
8-K
EX-99.1
r13n wzucd98rdlszok1
13 Nov 18
Eyegate Pharma Announces Positive Results In Second PRK Study
7:00am
8-K
EX-99.2
vxudrkts
13 Nov 18
Eyegate Pharma Announces Positive Results In Second PRK Study
7:00am
8-K
EX-99.1
uqj7inwikpfr
2 Oct 18
EyeGate Pharmaceuticals Signs Technology Transfer and License Agreement with SentrX Animal Care
6:58am
8-K
EX-99.1
ikuh8
25 Sep 18
EyeGate Pharmaceuticals Granted Additional 180 Days to Comply With Nasdaq Listing Rules
6:58am